European Heart Journal Advance Access published online on February 20, 2006
European Heart Journal, doi:10.1093/eurheartj/ehi812
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Cardiology, Castle Hill Hospital, University of Hull, Kingston-upon-Hull, UK
* To whom correspondence should be addressed.
Editorial
Threats, opportunities, and statins in the modern management of heart failure
John G.F. Cleland 1 *,
Huan Loh 1,
Jonathan Windram 1,
Kevin Goode 1,
and
Andrew L. Clark 1
John G.F. Cleland, E-mail: j.g.cleland{at}hull.ac.uk
The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Kjekshus, E. Apetrei, V. Barrios, M. Bohm, J. G.F. Cleland, J. H. Cornel, P. Dunselman, C. Fonseca, A. Goudev, P. Grande, et al. Rosuvastatin in Older Patients with Systolic Heart Failure N. Engl. J. Med., November 29, 2007; 357(22): 2248 - 2261. [Abstract] [Full Text] [PDF] |
||||
